Consistent with the GEPIA data, in 50 paired normal and tumor samples from colorectal cancer patients, FAXDC2 expression was significantly lower in the tumors compared with the normal tissues (Supplemental Figure 4A). This evidence concerns the gene FAXDC2 and colorectal cancer.